International Journal of Travel Medicine and Global Health. 2018;6(1):1-6 2 development of medical tourism concerns policy making and government regulations (Figure 1) . 11 By establishing a centralized system for promotion and training and reconfiguring goals, a country's approach can be standardized and its position in the medical tourism industry thereby strengthened. A second barrier may be the communication skills of the professional health team in addressing a patient's perspective and cultural differences. Foreign language, which makes the medical tourist vulnerable to miscommunication, is the third factor that can complicate the success of medical tourism. Furthermore, expertise is essential. Specialists who have received special training in working with international patients are necessary. Two factors contributing to the success of medical tourism are (a) promotion through overseas marketing strategies and (b) research and development activities. A facility should distinguish itself to attract foreign patients, because the same quality can be found in some other countries. Medical tourism can be economically beneficial due to its direct effect; its secondary effect is the spending of the medical tourist and his family or other company. Unfortunately, it can also have an opposite effect, as has been described for the situation in South Korea; the government of South Korea has invested more than $US400 million annually, while the number of medical tourists is showing a decreasing trend.
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In addition to these barriers, concerns have been raised regarding post-procedure health care. 12 Costs rise when medical tourists return with complications. The data existing at the present time is insufficient; however, analysis in the United Kingdom has indicated that, if handled correctly, medical tourism can have possible financial savings in future health care and social costs. 13 Further research and monitoring of the direct and indirect impacts of medical tourism on the economy should shed more light on this matter. In addition, international collaboration between countries with inbound and outbound medical tourists could improve not only the financial benefits, but also the quality of pre-and postmedical treatment care of medical tourists. 14 
Medical Tourism in Turkey
In Turkey, in parallel with the Health Transformation Program, health tourism has rapidly developed in the last ten years. [15] [16] [17] Both public and private hospitals offer high quality services with the latest technology and highly qualified personnel. Forty-nine health care institutions have been accredited by the Joint Commission International (JCI) in Turkey, one of the highest rates in the region. 18 19 By addressing these items, the barriers mentioned above could be avoided. The results of this program will be evaluated after 2018.
Among 30 medical tourism destinations, Turkey is ranked 14th in the Medical Tourism Index. 20 In 2013, an evaluation of medical tourism in Turkey was reported by Turkey's Ministry of Health. 19 In this report, the origin, purpose, preference, and other factors of international patients who received health care services were analyzed. The results showed that medical tourists preferred locations where traditional tourism already existed and cities where the infrastructure of health care services was good. Also, health care services producing at international standards and achieving JCI standards are clustered, and direct flights already land there. The most preferred cities were Antalya and Istanbul. Private hospitals were preferred by 91% of medical tourists, whereas government hospitals and university hospitals only received 9% of the medical tourists. Most of the medical tourists came from Libya, Germany, and Iraq. This data should be taken into consideration when planning and coordinating medical tourism.
A note should be made regarding one special group of medical tourists: those patients receiving services under a bilateral agreement on health, and therefore receiving health care abroad under their health insurance. In this respect, Turkey's Ministry of Health has made bilateral agreements on health with countries including Sudan, Afghanistan, Yemen, Albania, Azerbaijan, and Bahrain. 21 From these countries, a certain number of patients come to Turkey to receive treatment under a relevant protocol by the Ministry of Health. These patients are sent to public or university hospitals by an official letter from the General Directorate. Our experience at Erciyes University Bone Marrow Transplantation Center falls under this arrangement.
What Is Bone Marrow Transplantation?
Bone marrow transplantation is a medical procedure to replace damaged or destroyed bone marrow cells with healthy bone marrow. 22, 23 Bone marrow produces stem cells, immature cells that can produce all types of blood cells. At the present time, peripheral stem cell transplantation (SCT) is more commonly performed than bone marrow transplantation. 24, 25 Peripheral SCT is a procedure in which stem cells are collected from the peripheral blood after mobilization from the bone marrow with granulocyte-colony-stimulating factor (G-CSF), a growth factor. 26 There are two types of SCT. First, there is autologous SCT, in which stem cells previously collected from the patient himself are given back after high-dose chemotherapy as a "stem cell rescue". 27 Secondly, allogeneic SCT is a procedure in which mobilized stem cells from a healthy donor are given to a patient to evoke an immune response in the patient to cure a hematological cancer. 28 Patients can be pretreated with either a myeloablative regimen with chemotherapy with or without radiotherapy or a reduced intensity regimen. 29 Indications for an autologous SCT are multiple myeloma (MM), relapsed non-Hodgkin lymphoma (NHL), or Hodgkin lymphoma (HL). [30] [31] [32] [33] Sometimes, solid tumors such as in testis carcinoma, breast cancer, or autoimmune diseases such as systemic scleroderma are also indications for autologous transplantation. [34] [35] [36] [37] Indications for allogeneic SCT are either benign such as severe aplastic anemia or sickle cell disease and thalassemia or malignant hematological diseases. [38] [39] [40] [41] [42] Acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) are the most common indications, as shown in Figure 2 . 44, 45 In the Erciyes University BMTC, more than 700 autologous and more than 500 allogeneic SCTs have been conducted with JACIE Accreditation (Joint Accreditation Committee-ISCT & EBMT; ISCT: International Society for Cellular Therapy; EBMT: European Society for Blood and Marrow Transplantation). 46 Since 2016, an international collaboration has existed between Erciyes University and the King Hamed University Hospital (KHUH) in Bahrain. Since January 2016, 10 allogeneic SCTs and 10 autologous SCTs have been performed on international patients from Bahrain, as shown in patients), HL (1 patient), and NHL (1 patient). Before referral, a committee consisting of hematologists from our center and hemato-oncologists from KHUH approved the indication for autologous or allogeneic SCT. After a thorough pre-transplant procedure including a recent remission status of the disease, an assessment of cardiopulmonary status, and an assessment of mental status, the transplantation procedure could continue. When a patient was not in remission or had severe co-morbidities, close communication with KHUH regarding the further treatment plan of the patient was maintained. For all referred patients, close and regular communication was maintained between the center and KHUH. After discharge from the clinic, patients were closely monitored in our outpatient clinic. Depending on the clinical status, patients were sent to Bahrain varying from a few weeks to a few months after discharge. At all times during admission and also in the outpatient clinic, several translators were available. In 2016, transplant-related mortality (TRM) at 100 days among Bahrain patients was 0% compared to 2.6% in all patients. The TRM at 100 days for 2017 will be determined later. In total, 3 patients were re-admitted due to (expected) post-transplant morbidity. Although these numbers are relatively small, our first results show that the outcomes of these patients were similar to those of non-international patients. In our experience, the key to a successful collaboration between international hospitals is having close communication on the treatment plan of the international patient. Furthermore, a specialized team with knowledge on foreign patients is essential. Also, the continuing availability of medical translators is of utmost importance.
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Conclusion
Due to globalization, medical tourism has grown exponentially in the last decade. Several push and pull factors can be identified. Though medical tourism can have a huge beneficial impact on the economy of the hosting country, it can also have the opposite effect. Several barriers to medical tourism should be taken into account when making policy regarding the development of medical tourism. Further research should fill the gaps in indirect economic impact and implementation of earlier governmental policy, such as the results of the 4 components of the Turkey's Tenth Development Plan on the part of Health Tourism.
A brief remark on "publication bias" should be made regarding the current existing literature on the subject. 49, 50 A thorough literature search was made, but only articles in English were reviewed. It was noticed that literature from export countries emphasized the negative components of medical tourism, whereas import countries focused mostly on its positive aspects. As publications may not be equally presented in PubMed, one should be cautious not to develop a skewed view on the subject.
In our experience regarding medical tourists under the bilateral agreement of health, excellent medical treatment can be provided. The key to a successful collaboration between international hospitals is having close communication regarding the treatment plan of the international patient. Furthermore, a specialized team with knowledge on
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international patients is essential. Also, the continuing availability of medical translators is of utmost importance. The outcomes of a large group of international patients in comparison with non-international patients should be further studied.
